Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Product update

Avastin wound healing warning

The Pharmaceutical Journal31 OCT 2014

The summary of product characteristics for Avastin (bevacizumab; Roche) has been updated to warn that serious wound healing complications, including anastomotic complications, with a fatal outcome have been reported.

Citation: The Pharmaceutical Journal, 8 November 2014, Vol 293, No 7835, online | DOI: 10.1211/PJ.2014.20067009

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Log in Register

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Top Stories

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Related articles

Similar topics

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.